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Increasingly people are using human enhancement drugs (HED) to improve and augment their physical appearance.  Of particular 
interest is the injecting use of HE products, and the degree to which injecting of these products for muscle building, tanning and 
body ‘site’ enhancement has entered into mainstream society.  Users do not identify as injecting drug users and are less informed 
about risks associated with the injecting of these unregulated products such as potential for product adulteration, contamination 
and needle sharing. The study of HED sourcing and usage has not been carried out before and will contribute to policy development,  
regulation, clinical intervention, health promotion and harm reduction for injecting use of HEDs across the European Union. One of 
the unique aspects of this research is its examination of HED users use of the internet to source products, and how the internet 
influences their views and usage of such products. This research is in its preliminary stages.  
This research aims to investigate the contemporary user profile, sourcing route, product 
endorsement, risk perceptions and health outcomes of injected HEDs.  
The HEDs that form the focus for this study  are: 
• Anabolic steroid and growth hormones (CJC-1295, GHRP-6, GHRP-2 and selective 
      androgen receptor modulators (SARMs) 
• Melanotan I and II (tanning product) 
• ‘Site enhancement liquids or oils’ (i.e. Synthol, silicone) 
Months 1-36 
1. Literature Review 
2. IDUHED website 
launch  
3. Monitoring of several 
key websites, discussion 
forums, cyberpharmacies 
4.  online survey (n-1000) 
Months 6-14 
In depth Interviewing 
with users to investigate: 
how the injecting use of 
HEDs is socially organised 
and to examine  the 
experiences and risk 
negotiation of users 
Phase 3   
Months 18-24 
Thematic findings will be 
plotted against theories 
of risk decision 
making, emergent 
injecting habitus and 
negotiation of 
subcultural and 
cyber environments  
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• This study is unique and has not been done before. It will generate new data which will be disseminated as follows: 
• A dedicated IDUHED project website targeting lay public and HED users  
• A series of concise and clearly written fact-sheets for the general public will be prepared on research findings as they arise, giving 
information on harm and risks to users.  
• Peer reviewed articles in high indexed health, drug and sporting journals 
• Monthly snapshots identifying HED products sold and profile of users  through the project website  
• Oral/poster presentation of study findings at National and International Conferences.  
Anabolic Steroids Melanotan I & II 
Site Enhancement 
Oils or Liquids 
Background to Research  
Research Aim  
Open Research Data  
Human Enhancement Drugs  
Study Outcomes 
The study will achieve a better 
understanding of the user profile, 
examine the sociocultural and 
demographic profile and aetiology, 
cyber sourcing trends and 
consequences of this form of 
injecting drug use in order to inform 
and measure the effect of current 
legislative controls, develop 
recommendations for an early 
warning system for new 
emergent HED drugs, and ultimately 
contribute to the design of targeted 
online prevention and harm 
reduction brief interventions. 
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